SuperNova396

NATCO PHARMA - On Radar | 7 years ATH BO

做多
NSE:NATCOPHARM   NATCO PHARMA LTD
Price Analysis & Overview:

1. Double bottom on monthly.
2. Volumes on BO is not really great.
3. If the price sustains at higher levels, I will plan an entry.
4. RRR is favourable. Potenial is huge!
5. Earnings are strong.

Monthly TF view:

- Stay tuned for further insights, updates and trade safely!
- These are my personal views.
- If you liked the analysis, don't forget to leave a comment and boost the post. Happy trading!

Disclaimer: This is NOT a buy/sell recommendation. This post is meant for learning purposes only. Please, do your due diligence before investing.

Thanks & Regards,
Anubrata Ray

Anubrata Ray
免责声明

这些信息和出版物并不意味着也不构成TradingView提供或认可的金融、投资、交易或其它类型的建议或背书。请在使用条款阅读更多信息。